MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹335 Cr | ₹18 Cr | ₹9.76 Cr | ₹6.66 Cr | ₹2.64 Cr |
What is the latest Contingent Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹335 Cr |
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹9.76 Cr |
| Mar2023 | ₹6.66 Cr |
| Mar2022 | ₹2.64 Cr |
How is Contingent Liabilities of MOREPEN LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹335 Cr | 1,730.99 | |
| Mar2025 | ₹18 Cr | 87.61 | |
| Mar2024 | ₹9.76 Cr | 46.52 | |
| Mar2023 | ₹6.66 Cr | 152.33 | |
| Mar2022 | ₹2.64 Cr | - | |
Compare Contingent Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹4,940.2 Cr | -4.9% | -23.6% | 96.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -4.9% |
-23.6% |
96.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses